EIF2AK2 and viral infectious disease: Therefore, drugs that activate p-elF2α through PKR to promote SGs formation are expected to be a developed to control viral infection, but it is unclear whether SGs formation contributes to the antiviral effects of these compounds, and they likely exert an inhibitory effect on viral protein synthesis.